Professional Documents
Culture Documents
Dopamine Content
Dopamine Content
Dopamine !"#$ % drip rate $ ) * + ,# - %.$
-!/ ( !",$ ,# - ) $ keep BP> 90/60 , keep BPS> 100 => ( $/! order )$)- !")
1
Dopamine 2 : 1 % AB % C C / # Dopamine 2 mg (2000 mcg) FG 1 ml
I/- dopamine / - 200 mg 10 ml ! CB!J 1 amp *C C FG 100 ml
,G #K rate ! J% #$ % % *)$
! 10-20 mcg/kg/min ()*+,-. 30 mcg/kg/min
$ / /F)$)- !" FG % # %,J- FG % = K 50 JMC
,G #K minimum dose (10 mcg) $ ! 500 mcg/min = 0.5 mg/min
K/QB+ /F 15 ml/hr ,J-=> / )- 0.25 ml x 200 mg / # 0.5 mg/min UB$ ! dose
#)= =$ W
V % order /F,* ! C!J AB 10 amp UB 1 amp drip )-AB 6-7 . ! 1 #
4 amp + stat )=C# 1 amp ,# !J= K 5 amp $ F
2
1
Dopamine UB/,# %* K/QB+ / 1 $ / drip / #$ 6
microdrop/min /!$ ! 6 ml/hr. G % ! order /F,* !" = ! - M- )
JBF , FC 2 microdrop/min * + -!,# - %.$ $# 90/60
3
4
one day * $ ^.=a# -J B)$)- !" - / $ * => High alert drug UB /
# ! - c ,# review order -J C M !A ! CAB rate C 3!456-*67
-8 !9.:);!9<!.
2
5
Dopamine 2 : 1 rate 30 ml/hr */!! K/QB+ / 1 (rate 30 ml/hr ) !#$ rate #$
1 $ $.$ $#/ !)-)$J max dose (,G #K FG % # 50 . )- 20 mcg/kg/min )
6
Dopamine // $# 1.6 : 1 % AB %/ # Dopamine 1.6 mg FG 1 ml
UBA -J/ premixed /!$ ! Dopamine premixed 400 mg D5W 250 ml K/ /F/ 2 C*,*
1. = B+ ! C* => $# 2:1 G % )$%C*C ,G #K$ #$ 1.6 :1
2. !J 1 amp (200mg) C -.- 8 ml (160mg) *^! FG 100 ml
7
3
Dopamine 4 : 1 % AB % C C / # Dopamine 4 mg (4000 mcg) FG 1 ml
^.=a# /F $ / G - FG B ^ $# 4 :1 $ J !" *
,?!*?!.@A5@B;)5,C45 C4 3.2 mg/mL (3200 mcg) ^.= a#/G - FG B -. rate ,#!,.$)=-#
8 microdrop/min = 533 mcg/ min UB.$ $#/ !)- (-. #$ ,G #K K/QB+ / 1)
Dopamine Injection
C4! Dopamex injection
C46!45 Dobutamine ( indication $ )
A(99()*(5 J-I/- 200 mg C C 10 ml (20 mg 1 mL)
-J/ Dopamine premixed 200 mg C 400 mg D5W 250 ml $=V"! )$)-
G !W/ M ! C
?!49+5 !
1. + ^.=a# c # Shock // * % " $ l $ shock * %C-C*-
%# "- C *F%# =>
2. + ^.=a#,# - MC%J G $ " C =m Shock / J-
3. !^.=a#M ,%# C M ,) *F /J- " $ %
4. + ^.=a# J+ $ + M ,%# ! !J. , M! C C J+ * l /
A! ) )-
5. $# " !A$ =V # %=> = J-/BF
Pharmacokinetics : Onset : 5 /
Duration of action : < 10 /
Half-life : 2 /
?. 1. ^. %W$ : - J 1-5 mcg/kg/min ,$= ! - J, FC 1-4 mcg/kg/min
4
" 10-30 / AB 20 mcg/kg/min ( ^.=a#$# %W$) ^.=a#//=VW% occlusive vascular disease ,#
J 1 mcg/kg/min
^C $ !! hemodynamic BF ! - - /F
- - G 1-3 mcg/kg/min J renal blood flow, urine output
(! G 1-5 mcg/kg/min)
- -C 3-10 mcg/kg/min J cardiac output
(! G 5-15 mcg/kg/min)
- -. > 10 mcg/kg/min J total peripheral resistance, pulmonary pressure
Maximum dose : 50 mcg/kg/min
*,?!*?!.@A5@B;)5,C45 C4 3.2 mg/mL (3200 mcg) ^.= a#/G - FG
, )/\ * = J K )%C#/ FG $ G (hypovolumic shock) A
c # ,# - MC%J G )$ A) %= J)- - 175-280 mcg/ / F % J -
$ %J Noradrenaline 5 mcg/ / $ . #
2. -\ : J -# : 2-5 mcg/kg/min C ) %/,# - -!/
Maximum dose : 20 mcg/kg/min
(67@5,R.43@+. $
34+5 1 Dopamine (2:1) IV 10 mL/hr
#Jr/G
1. Dopamine (2:1) % AB Dopamine ,# %C* 2 mg/mL
2. Dopamine // M ! C=> - 200 mg/10 mL
3. C* FG /C$ # = J 100 mL * ^
4. G Dopamine 10 mL ^ FG /C* 100 mL )-,# 2 mg/mL
5. Rate / % ,* 10 mL/hr $ ! 0.167 mL/min
1 mL = 60 microdrop
A 0.167 mL $ ! 0.167x60 = 10 microdrop/min
"= Dopamine 10 mL ^ FG 100 mL C# % %C-C*--G -# 10 microdrop $ /
34+5 3 dopamine (1:1) 2 mcg/kg/min M-/ FG % #^.=a# 50 . % rate $ )
#Jr/G
1. dopamine 1:1 % ,# #$ C C 1ml / dopamine 1mg (1000mcg)
2. ^.=a#% 50 . )- ! 100 mcg/min % *$ ! 0.1 ml / min
3. 1ml = 60 microdrop - F 0.1 ml = 6 microdrop
- F ! C ! J% dopamine 1:1 iv rate 6 microdrop/min
S@*@T;99-;
1. A % %C-C*--G * -# D5W, D5NSS, D5RL , NSS, Mannitol
2. C # C C /=> -$ B% ^ alkali solution $ Sodium bicarbonate (NaHCO3)
?!4*A)@TU9
*53?45
1. *^ C C - l , #/"K%c.J% (25 oC) % * .\ (4 oC) )- 24 #M
2. C C /=C/ / * A.UJ)-U% * C#%
,V9
1. \! c C "K%c.J%
2. % A //=C/ => / FG C% *
4*+65@57
,C* ) / %# )$=> %# =#-, % %# =#-Q/ + ,# - MC%J .
% * G ) # I/!C ,# - MC%J . " %# ^J-%# C ) # I/!C
6
,WX5
1. #-. vital sign M-#-,# - MC%J C pulse " 2 /* J % C #-" 5 /*,#
- MC%J .$ -!,// (= K 80-100 mmHg systolic) %C F % J- " 5 /
2. #-. IV site #$ / extravasation % *)$ J- tissue necrosis )- A / #
/*!J^J-= J
3. !*/ ^J-= J $ %# \#C ^J-%# = J K=V # C
,# - MC%J C-C C+K /^J#U/-\ =>
4,*C4!9,-.?.
Antidote Supportive care )$/ specific antidote
*),)C4.5()ZU;69
1. /,# ! * (sound - alike) ,C ! Dobutamine
2. ,# ! ,G #K - ,G #K \# % ,#
C C / %
3. # %C-C*- (Extravasation)
(!?ZU;
1. ,# CJ => $# C => mg C !"= J K FG / * %)-,#
/ A.
2. c calculation sheet ,G #K*# ! - /^.=a#)- ! %.$ $# +
C )$J maximum dose
3. * / /*,C ,# \! %%$ *=m %J! ^J-
4. ! J% ^$ C*- - %W$ *=m J- extravasation * Dopamine /,"K! J
=> vesicant ,# / -.C G % $/ % $ C-J #$ / )%C )--/
References:
Drug Information handbook. 17th edition page 539-541
Intraveneous medication 2004 page 398-402
AFHS 2003 page 1231-1235
7